These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2846304)

  • 1. Restricted localization of functional vasoactive intestinal peptide (VIP) receptors in in vitro differentiated human colonic adenocarcinoma cells (HT29-D4).
    Fantini J; Martin JM; Luis J; Rémy L; Tirard A; Marvaldi J; Pichon J
    Eur J Cell Biol; 1988 Aug; 46(3):458-65. PubMed ID: 2846304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined ultrastructural and biochemical study of cellular processing of vasoactive intestinal peptide and its receptors in human colonic carcinoma cells in culture.
    Hejblum G; Gali P; Boissard C; Astesano A; Marie JC; Anteunis A; Hui Bon Hoa D; Rosselin G
    Cancer Res; 1988 Nov; 48(21):6201-10. PubMed ID: 2844402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of polarized apical expression and vectorial release of carcinoembryonic antigen (CEA) during the process of differentiation of HT29-D4 cells.
    Fantini J; Rognoni JB; Culouscou JM; Pommier G; Marvaldi J; Tirard A
    J Cell Physiol; 1989 Oct; 141(1):126-34. PubMed ID: 2674159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
    Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD
    Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cycloheximide induces accumulation of vasoactive intestinal peptide (VIP) binding sites at the cell surface of a human colonic adenocarcinoma cell line (HT29-D4). Evidence for the presence of an intracellular pool of VIP receptors.
    Luis J; Martin JM; el Battari A; Fantini J; Giannellini F; Marvaldi J; Pichon J
    Eur J Biochem; 1987 Sep; 167(2):391-6. PubMed ID: 3040409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of high affinity receptors for vasoactive intestinal peptide on human lymphocytes of B cell lineage.
    O'Dorisio MS; Shannon BT; Fleshman DJ; Campolito LB
    J Immunol; 1989 May; 142(10):3533-6. PubMed ID: 2541199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive intestinal peptide receptor/adenylate cyclase system: differences between agonist- and protein kinase C-mediated desensitization and further evidence for receptor internalization.
    Turner JT; Bollinger DW; Toews ML
    J Pharmacol Exp Ther; 1988 Nov; 247(2):417-23. PubMed ID: 2846820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive intestinal peptide and intraocular pressure: adenylate cyclase activation and binding sites for vasoactive intestinal peptide in membranes of ocular ciliary processes.
    Mittag TW; Tormay A; Podos SM
    J Pharmacol Exp Ther; 1987 Apr; 241(1):230-5. PubMed ID: 3033201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal peptide receptor regulation and reversible desensitization in human colonic carcinoma cells in culture.
    Boissard C; Marie JC; Hejblum G; Gespach C; Rosselin G
    Cancer Res; 1986 Sep; 46(9):4406-13. PubMed ID: 3015387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modifications of the binding properties of the human VIP receptor of IGR39 cells by sulfhydryl reagents.
    Fouchier F; Forget P; Pic P; Marvaldi J; Pichon J
    Eur J Cell Biol; 1992 Dec; 59(2):382-8. PubMed ID: 1337321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vasoactive intestinal peptide receptor in a human pancreatic carcinoma cell line].
    Chen Y
    Zhonghua Yi Xue Za Zhi; 1990 Mar; 70(3):135-7, 12. PubMed ID: 2163737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suramin inhibits vasoactive intestinal peptide (VIP) binding and VIP-induced cAMP accumulation into two human cancerous cell lines.
    Bellan C; Pic P; Marvaldi J; Fantini J; Pichon J
    Second Messengers Phosphoproteins; 1991; 13(4):163-71. PubMed ID: 1667418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired carcinoembryonic antigen release during the process of suramin-induced differentiation of the human colonic adenocarcinoma cell clone HT29-D4.
    Fantini J; Rognoni JB; Theveniau M; Pommier G; Marvaldi J
    J Cell Physiol; 1990 Jun; 143(3):468-74. PubMed ID: 2162847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubilization of the active vasoactive intestinal peptide receptor from human colonic adenocarcinoma cells.
    el Battari A; Martin JM; Luis J; Pouzol O; Secchi J; Marvaldi J; Pichon J
    J Biol Chem; 1988 Nov; 263(33):17685-9. PubMed ID: 2846575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor.
    Sreedharan SP; Patel DR; Huang JX; Goetzl EJ
    Biochem Biophys Res Commun; 1993 Jun; 193(2):546-53. PubMed ID: 8390245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of nuclear receptors for VIP on a human colonic adenocarcinoma cell line.
    Omary MB; Kagnoff MF
    Science; 1987 Dec; 238(4833):1578-81. PubMed ID: 2825352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suramin-treated HT29-D4 cells grown in the presence of glucose in permeable culture chambers form electrically active epithelial monolayers. A comparative study with HT29-D4 cells grown in the absence of glucose.
    Fantini J; Rognoni JB; Verrier B; Lehmann M; Roccabianca M; Mauchamp J; Marvaldi J
    Eur J Cell Biol; 1990 Feb; 51(1):110-9. PubMed ID: 2328732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HT 29, a model cell line: stimulation by the vasoactive intestinal peptide (VIP); VIP receptor structure and metabolism.
    Marchis-Mouren G; Martin JM; Luis J; el Battari A; Muller JM; Marvaldi J; Pichon J
    Biochimie; 1988 May; 70(5):663-71. PubMed ID: 2844304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photoaffinity labelling of the vasoactive-intestinal-peptide-binding site on intact human colonic adenocarcinoma cell line HT29-D4. Synthesis and use of photosensitive vasoactive-intestinal-peptide derivatives.
    Martin JM; Darbon H; Luis J; el Battari A; Marvaldi J; Pichon J
    Biochem J; 1988 Mar; 250(3):679-85. PubMed ID: 2839143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal peptide control of cyclic adenosine 3':5'-monophosphate levels in seven human colorectal adenocarcinoma cell lines in culture.
    Laburthe M; Rousset M; Chevalier G; Boissard C; Dupont C; Zweibaum A; Rosselin G
    Cancer Res; 1980 Jul; 40(7):2529-33. PubMed ID: 6248206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.